Peter Lurie, M.D., M.P.H. is Associate Commissioner for Public Health Strategy and Analysis in the Office of the Commissioner at the Food and Drug Administration. Prior to that he was Senior Advisor in the Office of Policy and Planning, where he worked on a number of policy issues, including antimicrobial resistance, drug shortages and the international dimensions of tobacco control.
Before coming to the FDA, he was Deputy Director of Public Citizen’s Health Research Group in Washington, D.C., where he addressed a variety of FDA regulatory policies, a number of specific drug and device issues, efforts to reduce worker exposure to hexavalent chromium and beryllium and excessive medical resident work hours. He had an earlier academic career at the University of California, San Francisco and the University of Michigan in which he studied needle exchange programs, ethical aspects of mother-to-infant HIV transmission studies and the economic and public health aspects of a number of HIV policies domestically and abroad.